Literature DB >> 1656992

Xanthine oxidase-catalyzed reduction of estrogen quinones to semiquinones and hydroquinones.

D Roy1, B Kalyanaraman, J G Liehr.   

Abstract

Metabolic redox cycling between the stilbene estrogen diethylstilbestrol (DES) and diethylstilbestrol-4',4"-quinone (DES Q) has been demonstrated previously. The xanthine and xanthine oxidase-catalyzed reduction of estrogen quinone has been studied in this work to understand the role of metabolic redox cycling in estrogen metabolism. Xanthine and xanthine oxidase catalyzed the reduction of DES Q to 44% Z-DES and 9% E-DES. This reaction was inhibited by the addition of superoxide dismutase or by a lack of oxygen (under anaerobic conditions). DES Q was also reduced in a non-enzymatic reaction by superoxide radicals generated by potassium superoxide and crown ether. The reaction between the O2-. and DES Q was also investigated by an electron spin resonance spin-trapping technique. The superoxide anion generated in an oxygen-saturated xanthine and xanthine oxidase system was detected as 5,5-dimethyl-1-pyrroline-1-oxide-superoxide adduct. The addition of DES Q or 2,3-estradiol quinone totally inhibited the formation of this adduct. The reduction of DES Q by superoxide radicals was taken as evidence that this reaction was one possible mechanism of xanthine and xanthine oxidase-mediated reduction. In addition, reduction of DES Q by direct electron transfer to quinone by the enzyme may also occur. The intermediate formation of semiquinone free radicals in the reduction is implied by the nature of the single electron transfer reactions and, in addition, has been demonstrated for the catechol estrogen by electron spin resonance measurements. It is concluded that the reduction of estrogen quinones to their hydroquinones by xanthine oxidase occurs by both one electron transfer to the quinone and by formation of superoxide which then reduces the quinone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656992     DOI: 10.1016/0006-2952(91)90433-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women.

Authors:  Y Wen; M C Doyle; L A Norris; M M Sinnott; T Cooke; R F Harrison; J Feely
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

2.  Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.

Authors:  A D Spigelman; K C Farmer; S Oliver; K P Nugent; P N Bennett; L J Notarianni; P Dobrocky; R K Phillips
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

3.  Estrogen, mitochondria, and growth of cancer and non-cancer cells.

Authors:  Quentin Felty; Deodutta Roy
Journal:  J Carcinog       Date:  2005-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.